Challenges for New Alzheimer’s Drugs

Created using ChatSlide

Explore the upcoming rollout of Donanemab in 2025, a promising treatment for early-stage Alzheimer's. This presentation delves into the challenges posed by logistical and infrastructure barriers, including the scarcity of imaging facilities and specialist staffing, especially in regional areas. We will also address the financial implications that patients face, given the high treatment costs and lack of PBS subsidisation. Emphasising safety protocols, we look at ARIA risk management, the...